Research with SNAC transgenic mouse models has shown that the presence of a-synuclein is not associated with the loss of dopaminergic neurons, despite the presence of a-synuclein aggregates in nerve cells and behavioral manifestations similar to those observed in PD patients [89]. The gene discussed is SNCA; the disease is Parkinson disease.